Epidemiology of acquired valvular heart disease

Canadian Journal of Cardiology

Volumn 30, Issue 9, 2014, Pages 962-970

  Iung, Bernard ^a   Vahanian, Alec ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AORTA STENOSIS; BACTERIAL ENDOCARDITIS; DEVELOPING COUNTRY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ENVIRONMENTAL FACTOR; EUROPE; HUMAN; IMAGE ANALYSIS; INDUSTRIALIZATION; MEDICAL HISTORY; MICROBIOLOGY; MITRAL VALVE REGURGITATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; REVIEW; RHEUMATIC HEART DISEASE; SCREENING TEST; SOCIAL STATUS; STAPHYLOCOCCUS; TRICUSPID VALVE DISEASE; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; DEVELOPED COUNTRIES; ENDOCARDITIS, BACTERIAL; EUROPE; HEART VALVE DISEASES; HUMANS; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE STENOSIS; PREVALENCE; RHEUMATIC HEART DISEASE; STAPHYLOCOCCAL INFECTIONS;

EID: 84906324655     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.03.022     Document Type: Review

References (70)

1. Iung B., Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011, 8:162-172.
2. Nkomo V.T., Gardin J.M., Skelton T.N., et al. Burden of valvular heart diseases: a population-based study. Lancet 2006, 368:1005-1011.
3. Iung B., Baron G., Butchart E.G., et al. Aprospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003, 24:1231-1243.
4. Iung B., Baron G., Tornos P., et al. Valvular heart disease in the community: a European experience. Curr Probl Cardiol 2007, 32:609-661.
5. Chang A.S., Smedira N.G., Chang C.L., et al. Cardiac surgery after mediastinal radiation: extent of exposure influences outcome. JThorac Cardiovasc Surg 2007, 133:404-413.
6. Bhattacharyya S., Schapira A.H., Mikhailidis D.P., Davar J. Drug-induced fibrotic valvular heart disease. Lancet 2009, 374:577-585.
7. Rajamannan N.M., Evans F.J., Aikawa E., et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: calcific aortic valve disease-2011 update. Circulation 2011, 124:1783-1791.
8. Lindroos M., Kupari M., Heikkila J., Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. JAm Coll Cardiol 1993, 21:1220-1225.
9. Stewart B.F., Siscovick D., Lind B.K., et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. JAm Coll Cardiol 1997, 29:630-634.
10. Eveborn G.W., Schirmer H., Heggelund G., Lunde P., Rasmussen K. The evolving epidemiology of valvular aortic stenosis. The Tromso study. Heart 2013, 99:396-400.
11. Berry C., Lloyd S.M., Wang Y., Macdonald A., Ford I. The changing course of aortic valve disease in Scotland: temporal trends in hospitalizations and mortality and prognostic importance of aortic stenosis. Eur Heart J 2013, 34:1538-1547.
12. Iung B., Vahanian A. Degenerative calcific aortic stenosis: a natural history. Heart 2012, 98(suppl 4):iv7-13.
13. Tutar E., Ekici F., Atalay S., Nacar N. The prevalence of bicuspid aortic valve in newborns by echocardiographic screening. Am Heart J 2005, 150:513-515.
14. Nistri S., Basso C., Marzari C., Mormino P., Thiene G. Frequency of bicuspid aortic valve in young male conscripts by echocardiogram. Am J Cardiol 2005, 96:718-721.
15. Go A.S., Mozaffarian D., Roger V.L., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127:e6-e245.
16. Michelena H.I., Desjardins V.A., Avierinos J.F., et al. Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation 2008, 117:2776-2784.
17. Roberts W.C., Ko J.M. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005, 111:920-925.
18. Cosmi J.E., Kort S., Tunick P.A., et al. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. Arch Intern Med 2002, 162:2345-2347.
19. Iung B. Management of asymptomatic aortic stenosis. Heart 2011, 97:253-259.
20. Ben-Dor I., Pichard A.D., Gonzalez M.A., et al. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation 2010, 122:S37-S42.
21. Leon M.B., Smith C.R., Mack M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. NEngl J Med 2010, 363:1597-1607.
22. Vahanian A., Alfieri O., Andreotti F., et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012, 33:2451-2496.
23. Yu H.T., Moon J., Yang W.I., et al. High prevalence of unrecognized chordae tendineae rupture in mitral valve prolapse patients undergoing valve replacement surgery. Can J Cardiol 2013, 29:1643-1648.
24. Lancellotti P., Moura L., Pierard L.A., et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010, 11:307-332.
25. Freed L.A., Levy D., Levine R.A., et al. Prevalence and clinical outcome of mitral-valve prolapse. NEngl J Med 1999, 341:1-7.
26. Barasch E., Gottdiener J.S., Larsen E.K., et al. Clinical significance of calcification of the fibrous skeleton of the heart and aortosclerosis in community dwelling elderly. The Cardiovascular Health Study (CHS). Am Heart J 2006, 151:39-47.
27. Avierinos J.F., Detaint D., Messika-Zeitoun D., Mohty D., Enriquez-Sarano M. Risk, determinants, and outcome implications of progression of mitral regurgitation after diagnosis of mitral valve prolapse in a single community. Am J Cardiol 2008, 101:662-667.
28. Avierinos J.F., Gersh B.J., Melton L.J., et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation 2002, 106:1355-1361.
29. Enriquez-Sarano M., Avierinos J.F., Messika-Zeitoun D., et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. NEngl J Med 2005, 352:875-883.
30. Tribouilloy C., Grigioni F., Avierinos J.F., et al. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. JAm Coll Cardiol 2009, 54:1961-1968.
31. Bursi F., Enriquez-Sarano M., Nkomo V.T., et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 2005, 111:295-301.
32. Varadarajan P., Sharma S., Heywood J.T., Pai R.G. High prevalence of clinically silent severe mitral regurgitation in patients with heart failure: role for echocardiography. JAm Soc Echocardiogr 2006, 19:1458-1461.
33. Rossi A., Dini F.L., Faggiano P., et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 2011, 97:1675-1680.
34. Agricola E., Stella S., Figini F., et al. Non-ischemic dilated cardiopathy: prognostic value of functional mitral regurgitation. Int J Cardiol 2011, 146:426-428.
35. Bursi F., Barbieri A., Grigioni F., et al. Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study. Eur J Heart Fail 2010, 12:382-388.
36. Deja M.A., Grayburn P.A., Sun B., et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation 2012, 125:2639-2648.
37. Bursi F., Weston S.A., Redfield M.M., et al. Systolic and diastolic heart failure in the community. JAMA 2006, 296:2209-2216.
38. Singh J.P., Evans J.C., Levy D., et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999, 83:897-902.
39. Reid C.L., Anton-Culver H., Yunis C., Gardin J.M. Prevalence and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). Am J Cardiol 2007, 99:830-834.
40. Detaint D., Michelena H.I., Nkomo V.T., et al. Aortic dilatation patterns and rates in adults with bicuspid aortic valves: a comparative study with Marfan syndrome and degenerative aortopathy. Heart 2014, 100:126-134.
41. Schaefer B.M., Lewin M.B., Stout K.K., et al. The bicuspid aortic valve: an integrated phenotypic classification of leaflet morphology and aortic root shape. Heart 2008, 94:1634-1638.
42. Padial L.R., Oliver A., Vivaldi M., et al. Doppler echocardiographic assessment of progression of aortic regurgitation. Am J Cardiol 1997, 80:306-314.
43. Detaint D., Messika-Zeitoun D., Maalouf J., et al. Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic regurgitation: a prospective study. JACC Cardiovasc Imaging 2008, 1:1-11.
44. Jondeau G., Detaint D., Tubach F., et al. Aortic event rate in the Marfan population: a cohort study. Circulation 2012, 125:226-232.
45. Michelena H.I., Khanna A.D., Mahoney D., et al. Incidence of aortic complications in patients with bicuspid aortic valves. JAMA 2011, 306:1104-1112.
46. Gordon S.P., Douglas P.S., Come P.C., Manning W.J. Two-dimensional and Doppler echocardiographic determinants of the natural history of mitral valve narrowing in patients with rheumatic mitral stenosis: implications for follow-up. JAm Coll Cardiol 1992, 19:968-973.
47. Chandrashekhar Y., Westaby S., Narula J. Mitral stenosis. Lancet 2009, 374:1271-1283.
48. Messika-Zeitoun D., Thomson H., Bellamy M., et al. Medical and surgical outcome of tricuspid regurgitation caused by flail leaflets. JThorac Cardiovasc Surg 2004, 128:296-302.
49. Selton-Suty C., Celard M., Le Moing V., et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 2012, 54:1230-1239.
50. Tleyjeh I.M., Abdel-Latif A., Rahbi H., et al. Asystematic review of population-based studies of infective endocarditis. Chest 2007, 132:1025-1035.
51. Sy R.W., Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J 2010, 31:1890-1897.
52. Fedeli U., Schievano E., Buonfrate D., Pellizzer G., Spolaore P. Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis 2011, 11:48.
53. Slipczuk L., Codolosa J.N., Davila C.D., et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One 2013, 8:e82665.
54. Duval X., Delahaye F., Alla F., et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. JAm Coll Cardiol 2012, 59:1968-1976.
55. Fernandez-Hidalgo N., Almirante B., Tornos P., et al. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis 2008, 47:1287-1297.
56. Duval X. Simplification of the prophylaxis of endocarditis: we were right!. Arch Cardiovasc Dis 2013, 106:69-71.
57. Sliwa K., Carrington M., Mayosi B.M., et al. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J 2010, 31:719-727.
58. Tibazarwa K.B., Volmink J.A., Mayosi B.M. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 2008, 94:1534-1540.
59. Carapetis J.R. Rheumatic heart disease in Asia. Circulation 2008, 118:2748-2753.
60. Rizvi S.F., Khan M.A., Kundi A., et al. Status of rheumatic heart disease in rural Pakistan. Heart 2004, 90:394-399.
61. Marijon E., Ou P., Celermajer D.S., et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. NEngl J Med 2007, 357:470-476.
62. Marijon E., Celermajer D.S., Tafflet M., et al. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation 2009, 120:663-668.
63. Demirbag R., Sade L.E., Aydin M., Bozkurt A., Acarturk E. The Turkish registry of heart valve disease. Turk Kardiyol Dern Ars 2013, 41:1-10.
64. Rosenhek R., Iung B., Tornos P., et al. ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 2012, 33:822-828. 8a, 8b.
65. Adult Cardiac Surgery Database. Executive Summary. 10 Years. STS Period Ending 09/30/2013. Available at:. Accessed February 17,2014. http://www.sts.org/sites/default/files/documents/4thHarvestExecutiveSummary.pdf.
66. Bridgewater B., Gummert J., Walton P., Kinsman R. Fourth EACTS adult cardiac surgical database report 2010 2010, Dendrite Clinical Systems Ltd, UK, Henly-on-Thames.
67. Hassan A., Newman A.M., Gong Y., et al. Use of valve surgery in Canada. Can J Cardiol 2004, 20:149-154.
68. Brown J.M., O'Brien S.M., Wu C., et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. JThorac Cardiovasc Surg 2009, 137:82-90.
69. Grant S.W., Devbhandari M.P., Grayson A.D., et al. What is the impact of providing a transcatheter aortic valve implantation service on conventional aortic valve surgical activity: patient risk factors and outcomes in the first 2 years. Heart 2010, 96:1633-1637.
70. Malaisrie S.C., Tuday E., Lapin B., et al. Transcatheter aortic valve implantation decreases the rate of unoperated aortic stenosis. Eur J Cardiothorac Surg 2011, 40:43-48.